Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-01

Clinical Trial Update: Evaluating the Benefits of Physiologic Insulin Delivery [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating physiologic insulin delivery for type 1 diabetes has completed. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Stanford University | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED | Results posted: 2024-10-01